nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—CYP3A7—Simvastatin—atherosclerosis	0.0666	0.0957	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Simvastatin—atherosclerosis	0.0666	0.0957	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Lovastatin—atherosclerosis	0.0652	0.0937	CbGbCtD
Fentanyl—CYP3A7—Lovastatin—atherosclerosis	0.0652	0.0937	CbGbCtD
Fentanyl—CYP3A5—Rosuvastatin—atherosclerosis	0.0537	0.0772	CbGbCtD
Fentanyl—CYP3A5—Simvastatin—atherosclerosis	0.05	0.0718	CbGbCtD
Fentanyl—CYP3A5—Lovastatin—atherosclerosis	0.0489	0.0703	CbGbCtD
Fentanyl—CYP3A5—Pravastatin—atherosclerosis	0.0489	0.0703	CbGbCtD
Fentanyl—ABCB1—Ezetimibe—atherosclerosis	0.035	0.0503	CbGbCtD
Fentanyl—ABCB1—Simvastatin—atherosclerosis	0.0325	0.0467	CbGbCtD
Fentanyl—ABCB1—Lovastatin—atherosclerosis	0.0318	0.0457	CbGbCtD
Fentanyl—ABCB1—Pravastatin—atherosclerosis	0.0318	0.0457	CbGbCtD
Fentanyl—CYP3A4—Ezetimibe—atherosclerosis	0.021	0.0301	CbGbCtD
Fentanyl—CYP3A4—Rosuvastatin—atherosclerosis	0.021	0.0301	CbGbCtD
Fentanyl—CYP3A4—Simvastatin—atherosclerosis	0.0195	0.028	CbGbCtD
Fentanyl—CYP3A4—Lovastatin—atherosclerosis	0.0191	0.0274	CbGbCtD
Fentanyl—CYP3A4—Pravastatin—atherosclerosis	0.0191	0.0274	CbGbCtD
Fentanyl—Bepotastine—HRH1—atherosclerosis	0.00118	0.164	CrCbGaD
Fentanyl—Antazoline—HRH1—atherosclerosis	0.00092	0.128	CrCbGaD
Fentanyl—Astemizole—HRH1—atherosclerosis	0.000716	0.0997	CrCbGaD
Fentanyl—Diphenylpyraline—HRH1—atherosclerosis	0.000607	0.0845	CrCbGaD
Fentanyl—Ifenprodil—HRH1—atherosclerosis	0.000574	0.08	CrCbGaD
Fentanyl—Fexofenadine—HRH1—atherosclerosis	0.00051	0.0711	CrCbGaD
Fentanyl—Cyclizine—HRH1—atherosclerosis	0.000488	0.0681	CrCbGaD
Fentanyl—Benzatropine—HRH1—atherosclerosis	0.000465	0.0648	CrCbGaD
Fentanyl—Benazepril—MTHFR—atherosclerosis	0.00042	0.0585	CrCbGaD
Fentanyl—Quinapril—ACE—atherosclerosis	0.000393	0.0548	CrCbGaD
Fentanyl—Benazepril—ACE—atherosclerosis	0.000342	0.0477	CrCbGaD
Fentanyl—Tinnitus—Pravastatin—atherosclerosis	0.000299	0.00131	CcSEcCtD
Fentanyl—Malaise—Lovastatin—atherosclerosis	0.000298	0.0013	CcSEcCtD
Fentanyl—Flushing—Pravastatin—atherosclerosis	0.000298	0.0013	CcSEcCtD
Fentanyl—Cardiac disorder—Pravastatin—atherosclerosis	0.000298	0.0013	CcSEcCtD
Fentanyl—Muscle spasms—Simvastatin—atherosclerosis	0.000297	0.0013	CcSEcCtD
Fentanyl—Vertigo—Lovastatin—atherosclerosis	0.000297	0.0013	CcSEcCtD
Fentanyl—Angiopathy—Niacin—atherosclerosis	0.000296	0.00129	CcSEcCtD
Fentanyl—Leukopenia—Lovastatin—atherosclerosis	0.000296	0.00129	CcSEcCtD
Fentanyl—Chills—Niacin—atherosclerosis	0.000293	0.00128	CcSEcCtD
Fentanyl—Malaise—Ezetimibe—atherosclerosis	0.000292	0.00128	CcSEcCtD
Fentanyl—Vision blurred—Simvastatin—atherosclerosis	0.000291	0.00127	CcSEcCtD
Fentanyl—Arrhythmia—Niacin—atherosclerosis	0.000291	0.00127	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00029	0.00127	CcSEcCtD
Fentanyl—Tremor—Simvastatin—atherosclerosis	0.00029	0.00126	CcSEcCtD
Fentanyl—Alopecia—Niacin—atherosclerosis	0.000288	0.00126	CcSEcCtD
Fentanyl—Chills—Pravastatin—atherosclerosis	0.000288	0.00126	CcSEcCtD
Fentanyl—Insomnia—Rosuvastatin—atherosclerosis	0.000288	0.00126	CcSEcCtD
Fentanyl—Ill-defined disorder—Simvastatin—atherosclerosis	0.000287	0.00125	CcSEcCtD
Fentanyl—Arrhythmia—Pravastatin—atherosclerosis	0.000287	0.00125	CcSEcCtD
Fentanyl—Palpitations—Ezetimibe—atherosclerosis	0.000287	0.00125	CcSEcCtD
Fentanyl—Paraesthesia—Rosuvastatin—atherosclerosis	0.000286	0.00125	CcSEcCtD
Fentanyl—Anaemia—Simvastatin—atherosclerosis	0.000286	0.00125	CcSEcCtD
Fentanyl—Malnutrition—Niacin—atherosclerosis	0.000284	0.00124	CcSEcCtD
Fentanyl—Erythema—Niacin—atherosclerosis	0.000284	0.00124	CcSEcCtD
Fentanyl—Alopecia—Pravastatin—atherosclerosis	0.000284	0.00124	CcSEcCtD
Fentanyl—Cough—Ezetimibe—atherosclerosis	0.000283	0.00124	CcSEcCtD
Fentanyl—Myalgia—Lovastatin—atherosclerosis	0.000281	0.00123	CcSEcCtD
Fentanyl—Chest pain—Lovastatin—atherosclerosis	0.000281	0.00123	CcSEcCtD
Fentanyl—Arthralgia—Lovastatin—atherosclerosis	0.000281	0.00123	CcSEcCtD
Fentanyl—Anxiety—Lovastatin—atherosclerosis	0.00028	0.00122	CcSEcCtD
Fentanyl—Dyspepsia—Rosuvastatin—atherosclerosis	0.00028	0.00122	CcSEcCtD
Fentanyl—Hypertension—Ezetimibe—atherosclerosis	0.00028	0.00122	CcSEcCtD
Fentanyl—Flatulence—Niacin—atherosclerosis	0.00028	0.00122	CcSEcCtD
Fentanyl—Malaise—Simvastatin—atherosclerosis	0.000279	0.00122	CcSEcCtD
Fentanyl—Tension—Niacin—atherosclerosis	0.000279	0.00122	CcSEcCtD
Fentanyl—Discomfort—Lovastatin—atherosclerosis	0.000278	0.00121	CcSEcCtD
Fentanyl—Vertigo—Simvastatin—atherosclerosis	0.000278	0.00121	CcSEcCtD
Fentanyl—Leukopenia—Simvastatin—atherosclerosis	0.000277	0.00121	CcSEcCtD
Fentanyl—Arthralgia—Ezetimibe—atherosclerosis	0.000276	0.0012	CcSEcCtD
Fentanyl—Myalgia—Ezetimibe—atherosclerosis	0.000276	0.0012	CcSEcCtD
Fentanyl—Chest pain—Ezetimibe—atherosclerosis	0.000276	0.0012	CcSEcCtD
Fentanyl—Nervousness—Niacin—atherosclerosis	0.000276	0.0012	CcSEcCtD
Fentanyl—Flatulence—Pravastatin—atherosclerosis	0.000275	0.0012	CcSEcCtD
Fentanyl—Dry mouth—Lovastatin—atherosclerosis	0.000275	0.0012	CcSEcCtD
Fentanyl—Tension—Pravastatin—atherosclerosis	0.000274	0.0012	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000274	0.0012	CcSEcCtD
Fentanyl—Dysgeusia—Pravastatin—atherosclerosis	0.000274	0.00119	CcSEcCtD
Fentanyl—Muscle spasms—Niacin—atherosclerosis	0.000273	0.00119	CcSEcCtD
Fentanyl—Discomfort—Ezetimibe—atherosclerosis	0.000273	0.00119	CcSEcCtD
Fentanyl—Constipation—Rosuvastatin—atherosclerosis	0.000272	0.00119	CcSEcCtD
Fentanyl—Pain—Rosuvastatin—atherosclerosis	0.000272	0.00119	CcSEcCtD
Fentanyl—Confusional state—Lovastatin—atherosclerosis	0.000272	0.00119	CcSEcCtD
Fentanyl—Nervousness—Pravastatin—atherosclerosis	0.000272	0.00119	CcSEcCtD
Fentanyl—Dry mouth—Ezetimibe—atherosclerosis	0.00027	0.00118	CcSEcCtD
Fentanyl—Anaphylactic shock—Lovastatin—atherosclerosis	0.00027	0.00118	CcSEcCtD
Fentanyl—Muscle spasms—Pravastatin—atherosclerosis	0.000269	0.00117	CcSEcCtD
Fentanyl—Infection—Lovastatin—atherosclerosis	0.000268	0.00117	CcSEcCtD
Fentanyl—Vision blurred—Niacin—atherosclerosis	0.000268	0.00117	CcSEcCtD
Fentanyl—Confusional state—Ezetimibe—atherosclerosis	0.000267	0.00116	CcSEcCtD
Fentanyl—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000265	0.00116	CcSEcCtD
Fentanyl—Thrombocytopenia—Lovastatin—atherosclerosis	0.000264	0.00115	CcSEcCtD
Fentanyl—Vision blurred—Pravastatin—atherosclerosis	0.000263	0.00115	CcSEcCtD
Fentanyl—Myalgia—Simvastatin—atherosclerosis	0.000263	0.00115	CcSEcCtD
Fentanyl—Arthralgia—Simvastatin—atherosclerosis	0.000263	0.00115	CcSEcCtD
Fentanyl—Chest pain—Simvastatin—atherosclerosis	0.000263	0.00115	CcSEcCtD
Fentanyl—Infection—Ezetimibe—atherosclerosis	0.000263	0.00115	CcSEcCtD
Fentanyl—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000262	0.00115	CcSEcCtD
Fentanyl—Anxiety—Simvastatin—atherosclerosis	0.000262	0.00115	CcSEcCtD
Fentanyl—Tremor—Pravastatin—atherosclerosis	0.000262	0.00114	CcSEcCtD
Fentanyl—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00026	0.00114	CcSEcCtD
Fentanyl—Discomfort—Simvastatin—atherosclerosis	0.00026	0.00114	CcSEcCtD
Fentanyl—Nervous system disorder—Ezetimibe—atherosclerosis	0.00026	0.00113	CcSEcCtD
Fentanyl—Ill-defined disorder—Pravastatin—atherosclerosis	0.000259	0.00113	CcSEcCtD
Fentanyl—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000259	0.00113	CcSEcCtD
Fentanyl—Anaemia—Pravastatin—atherosclerosis	0.000258	0.00113	CcSEcCtD
Fentanyl—Anorexia—Lovastatin—atherosclerosis	0.000257	0.00112	CcSEcCtD
Fentanyl—Skin disorder—Ezetimibe—atherosclerosis	0.000257	0.00112	CcSEcCtD
Fentanyl—Vertigo—Niacin—atherosclerosis	0.000255	0.00111	CcSEcCtD
Fentanyl—Syncope—Niacin—atherosclerosis	0.000255	0.00111	CcSEcCtD
Fentanyl—Confusional state—Simvastatin—atherosclerosis	0.000254	0.00111	CcSEcCtD
Fentanyl—Leukopenia—Niacin—atherosclerosis	0.000254	0.00111	CcSEcCtD
Fentanyl—Urticaria—Rosuvastatin—atherosclerosis	0.000253	0.0011	CcSEcCtD
Fentanyl—Oedema—Simvastatin—atherosclerosis	0.000252	0.0011	CcSEcCtD
Fentanyl—Anaphylactic shock—Simvastatin—atherosclerosis	0.000252	0.0011	CcSEcCtD
Fentanyl—Malaise—Pravastatin—atherosclerosis	0.000252	0.0011	CcSEcCtD
Fentanyl—Abdominal pain—Rosuvastatin—atherosclerosis	0.000252	0.0011	CcSEcCtD
Fentanyl—Vertigo—Pravastatin—atherosclerosis	0.000251	0.0011	CcSEcCtD
Fentanyl—Palpitations—Niacin—atherosclerosis	0.000251	0.0011	CcSEcCtD
Fentanyl—Infection—Simvastatin—atherosclerosis	0.000251	0.00109	CcSEcCtD
Fentanyl—Leukopenia—Pravastatin—atherosclerosis	0.00025	0.00109	CcSEcCtD
Fentanyl—Loss of consciousness—Niacin—atherosclerosis	0.00025	0.00109	CcSEcCtD
Fentanyl—Cough—Niacin—atherosclerosis	0.000248	0.00108	CcSEcCtD
Fentanyl—Thrombocytopenia—Simvastatin—atherosclerosis	0.000247	0.00108	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000246	0.00107	CcSEcCtD
Fentanyl—Insomnia—Lovastatin—atherosclerosis	0.000244	0.00107	CcSEcCtD
Fentanyl—Cough—Pravastatin—atherosclerosis	0.000244	0.00106	CcSEcCtD
Fentanyl—Paraesthesia—Lovastatin—atherosclerosis	0.000242	0.00106	CcSEcCtD
Fentanyl—Arthralgia—Niacin—atherosclerosis	0.000242	0.00106	CcSEcCtD
Fentanyl—Myalgia—Niacin—atherosclerosis	0.000242	0.00106	CcSEcCtD
Fentanyl—Hypertension—Pravastatin—atherosclerosis	0.000241	0.00105	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000241	0.00105	CcSEcCtD
Fentanyl—Anorexia—Simvastatin—atherosclerosis	0.000241	0.00105	CcSEcCtD
Fentanyl—Dyspnoea—Lovastatin—atherosclerosis	0.000241	0.00105	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.00024	0.00105	CcSEcCtD
Fentanyl—Insomnia—Ezetimibe—atherosclerosis	0.000239	0.00104	CcSEcCtD
Fentanyl—Diphenhydramine—HRH1—atherosclerosis	0.000239	0.0333	CrCbGaD
Fentanyl—Arthralgia—Pravastatin—atherosclerosis	0.000238	0.00104	CcSEcCtD
Fentanyl—Myalgia—Pravastatin—atherosclerosis	0.000238	0.00104	CcSEcCtD
Fentanyl—Chest pain—Pravastatin—atherosclerosis	0.000238	0.00104	CcSEcCtD
Fentanyl—Paraesthesia—Ezetimibe—atherosclerosis	0.000238	0.00104	CcSEcCtD
Fentanyl—Dyspepsia—Lovastatin—atherosclerosis	0.000238	0.00104	CcSEcCtD
Fentanyl—Anxiety—Pravastatin—atherosclerosis	0.000237	0.00104	CcSEcCtD
Fentanyl—Dry mouth—Niacin—atherosclerosis	0.000236	0.00103	CcSEcCtD
Fentanyl—Dyspnoea—Ezetimibe—atherosclerosis	0.000236	0.00103	CcSEcCtD
Fentanyl—Discomfort—Pravastatin—atherosclerosis	0.000235	0.00103	CcSEcCtD
Fentanyl—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000235	0.00102	CcSEcCtD
Fentanyl—Decreased appetite—Lovastatin—atherosclerosis	0.000235	0.00102	CcSEcCtD
Fentanyl—Dyspepsia—Ezetimibe—atherosclerosis	0.000233	0.00102	CcSEcCtD
Fentanyl—Fatigue—Lovastatin—atherosclerosis	0.000233	0.00102	CcSEcCtD
Fentanyl—Oedema—Niacin—atherosclerosis	0.000232	0.00101	CcSEcCtD
Fentanyl—Anaphylactic shock—Niacin—atherosclerosis	0.000232	0.00101	CcSEcCtD
Fentanyl—Pain—Lovastatin—atherosclerosis	0.000231	0.00101	CcSEcCtD
Fentanyl—Constipation—Lovastatin—atherosclerosis	0.000231	0.00101	CcSEcCtD
Fentanyl—Confusional state—Pravastatin—atherosclerosis	0.00023	0.001	CcSEcCtD
Fentanyl—Decreased appetite—Ezetimibe—atherosclerosis	0.00023	0.001	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00023	0.001	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000228	0.000997	CcSEcCtD
Fentanyl—Asthenia—Rosuvastatin—atherosclerosis	0.000228	0.000997	CcSEcCtD
Fentanyl—Insomnia—Simvastatin—atherosclerosis	0.000228	0.000996	CcSEcCtD
Fentanyl—Anaphylactic shock—Pravastatin—atherosclerosis	0.000228	0.000996	CcSEcCtD
Fentanyl—Oedema—Pravastatin—atherosclerosis	0.000228	0.000996	CcSEcCtD
Fentanyl—Fatigue—Ezetimibe—atherosclerosis	0.000228	0.000996	CcSEcCtD
Fentanyl—Shock—Niacin—atherosclerosis	0.000228	0.000995	CcSEcCtD
Fentanyl—Infection—Pravastatin—atherosclerosis	0.000227	0.000989	CcSEcCtD
Fentanyl—Paraesthesia—Simvastatin—atherosclerosis	0.000227	0.000989	CcSEcCtD
Fentanyl—Pain—Ezetimibe—atherosclerosis	0.000226	0.000988	CcSEcCtD
Fentanyl—Constipation—Ezetimibe—atherosclerosis	0.000226	0.000988	CcSEcCtD
Fentanyl—Tachycardia—Niacin—atherosclerosis	0.000226	0.000987	CcSEcCtD
Fentanyl—Pruritus—Rosuvastatin—atherosclerosis	0.000225	0.000983	CcSEcCtD
Fentanyl—Skin disorder—Niacin—atherosclerosis	0.000225	0.000982	CcSEcCtD
Fentanyl—Dyspnoea—Simvastatin—atherosclerosis	0.000225	0.000982	CcSEcCtD
Fentanyl—Hyperhidrosis—Niacin—atherosclerosis	0.000224	0.000978	CcSEcCtD
Fentanyl—Thrombocytopenia—Pravastatin—atherosclerosis	0.000223	0.000975	CcSEcCtD
Fentanyl—Feeling abnormal—Lovastatin—atherosclerosis	0.000222	0.00097	CcSEcCtD
Fentanyl—Dyspepsia—Simvastatin—atherosclerosis	0.000222	0.00097	CcSEcCtD
Fentanyl—Anorexia—Niacin—atherosclerosis	0.000221	0.000964	CcSEcCtD
Fentanyl—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000221	0.000963	CcSEcCtD
Fentanyl—Hyperhidrosis—Pravastatin—atherosclerosis	0.000221	0.000963	CcSEcCtD
Fentanyl—Decreased appetite—Simvastatin—atherosclerosis	0.000219	0.000958	CcSEcCtD
Fentanyl—Feeling abnormal—Ezetimibe—atherosclerosis	0.000218	0.000952	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000218	0.000951	CcSEcCtD
Fentanyl—Diarrhoea—Rosuvastatin—atherosclerosis	0.000218	0.000951	CcSEcCtD
Fentanyl—Fatigue—Simvastatin—atherosclerosis	0.000218	0.00095	CcSEcCtD
Fentanyl—Anorexia—Pravastatin—atherosclerosis	0.000217	0.000949	CcSEcCtD
Fentanyl—Hypotension—Niacin—atherosclerosis	0.000217	0.000945	CcSEcCtD
Fentanyl—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000216	0.000945	CcSEcCtD
Fentanyl—Pain—Simvastatin—atherosclerosis	0.000216	0.000942	CcSEcCtD
Fentanyl—Constipation—Simvastatin—atherosclerosis	0.000216	0.000942	CcSEcCtD
Fentanyl—Urticaria—Lovastatin—atherosclerosis	0.000214	0.000936	CcSEcCtD
Fentanyl—Body temperature increased—Lovastatin—atherosclerosis	0.000213	0.000931	CcSEcCtD
Fentanyl—Abdominal pain—Lovastatin—atherosclerosis	0.000213	0.000931	CcSEcCtD
Fentanyl—Alfentanil—ALB—atherosclerosis	0.000213	0.0296	CrCbGaD
Fentanyl—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000211	0.000922	CcSEcCtD
Fentanyl—Dizziness—Rosuvastatin—atherosclerosis	0.000211	0.000919	CcSEcCtD
Fentanyl—Urticaria—Ezetimibe—atherosclerosis	0.00021	0.000918	CcSEcCtD
Fentanyl—Insomnia—Niacin—atherosclerosis	0.00021	0.000915	CcSEcCtD
Fentanyl—Body temperature increased—Ezetimibe—atherosclerosis	0.000209	0.000913	CcSEcCtD
Fentanyl—Abdominal pain—Ezetimibe—atherosclerosis	0.000209	0.000913	CcSEcCtD
Fentanyl—Paraesthesia—Niacin—atherosclerosis	0.000208	0.000908	CcSEcCtD
Fentanyl—Feeling abnormal—Simvastatin—atherosclerosis	0.000208	0.000908	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000208	0.000907	CcSEcCtD
Fentanyl—Dyspnoea—Niacin—atherosclerosis	0.000207	0.000902	CcSEcCtD
Fentanyl—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000206	0.000901	CcSEcCtD
Fentanyl—Insomnia—Pravastatin—atherosclerosis	0.000206	0.000901	CcSEcCtD
Fentanyl—Somnolence—Niacin—atherosclerosis	0.000206	0.000899	CcSEcCtD
Fentanyl—Paraesthesia—Pravastatin—atherosclerosis	0.000205	0.000894	CcSEcCtD
Fentanyl—Dyspepsia—Niacin—atherosclerosis	0.000204	0.00089	CcSEcCtD
Fentanyl—Dyspnoea—Pravastatin—atherosclerosis	0.000203	0.000888	CcSEcCtD
Fentanyl—Decreased appetite—Niacin—atherosclerosis	0.000201	0.000879	CcSEcCtD
Fentanyl—Dyspepsia—Pravastatin—atherosclerosis	0.000201	0.000877	CcSEcCtD
Fentanyl—Rash—Rosuvastatin—atherosclerosis	0.000201	0.000876	CcSEcCtD
Fentanyl—Dermatitis—Rosuvastatin—atherosclerosis	0.000201	0.000875	CcSEcCtD
Fentanyl—Urticaria—Simvastatin—atherosclerosis	0.0002	0.000875	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Niacin—atherosclerosis	0.0002	0.000873	CcSEcCtD
Fentanyl—Abdominal pain—Simvastatin—atherosclerosis	0.0002	0.000871	CcSEcCtD
Fentanyl—Body temperature increased—Simvastatin—atherosclerosis	0.0002	0.000871	CcSEcCtD
Fentanyl—Headache—Rosuvastatin—atherosclerosis	0.000199	0.000871	CcSEcCtD
Fentanyl—Hypersensitivity—Lovastatin—atherosclerosis	0.000199	0.000868	CcSEcCtD
Fentanyl—Decreased appetite—Pravastatin—atherosclerosis	0.000198	0.000866	CcSEcCtD
Fentanyl—Pain—Niacin—atherosclerosis	0.000198	0.000865	CcSEcCtD
Fentanyl—Fatigue—Pravastatin—atherosclerosis	0.000197	0.000859	CcSEcCtD
Fentanyl—Pain—Pravastatin—atherosclerosis	0.000195	0.000852	CcSEcCtD
Fentanyl—Constipation—Pravastatin—atherosclerosis	0.000195	0.000852	CcSEcCtD
Fentanyl—Hypersensitivity—Ezetimibe—atherosclerosis	0.000195	0.000851	CcSEcCtD
Fentanyl—Asthenia—Lovastatin—atherosclerosis	0.000194	0.000845	CcSEcCtD
Fentanyl—Pruritus—Lovastatin—atherosclerosis	0.000191	0.000833	CcSEcCtD
Fentanyl—Asthenia—Ezetimibe—atherosclerosis	0.00019	0.000829	CcSEcCtD
Fentanyl—Gastrointestinal pain—Niacin—atherosclerosis	0.000189	0.000827	CcSEcCtD
Fentanyl—Nausea—Rosuvastatin—atherosclerosis	0.000189	0.000825	CcSEcCtD
Fentanyl—Feeling abnormal—Pravastatin—atherosclerosis	0.000188	0.000821	CcSEcCtD
Fentanyl—Pruritus—Ezetimibe—atherosclerosis	0.000187	0.000817	CcSEcCtD
Fentanyl—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000187	0.000814	CcSEcCtD
Fentanyl—Hypersensitivity—Simvastatin—atherosclerosis	0.000186	0.000812	CcSEcCtD
Fentanyl—Diarrhoea—Lovastatin—atherosclerosis	0.000185	0.000806	CcSEcCtD
Fentanyl—Urticaria—Niacin—atherosclerosis	0.000184	0.000804	CcSEcCtD
Fentanyl—Abdominal pain—Niacin—atherosclerosis	0.000183	0.0008	CcSEcCtD
Fentanyl—Body temperature increased—Niacin—atherosclerosis	0.000183	0.0008	CcSEcCtD
Fentanyl—Urticaria—Pravastatin—atherosclerosis	0.000181	0.000791	CcSEcCtD
Fentanyl—Asthenia—Simvastatin—atherosclerosis	0.000181	0.00079	CcSEcCtD
Fentanyl—Diarrhoea—Ezetimibe—atherosclerosis	0.000181	0.00079	CcSEcCtD
Fentanyl—Abdominal pain—Pravastatin—atherosclerosis	0.00018	0.000787	CcSEcCtD
Fentanyl—Body temperature increased—Pravastatin—atherosclerosis	0.00018	0.000787	CcSEcCtD
Fentanyl—Pruritus—Simvastatin—atherosclerosis	0.000179	0.000779	CcSEcCtD
Fentanyl—Dizziness—Lovastatin—atherosclerosis	0.000178	0.000779	CcSEcCtD
Fentanyl—Dizziness—Ezetimibe—atherosclerosis	0.000175	0.000764	CcSEcCtD
Fentanyl—Diarrhoea—Simvastatin—atherosclerosis	0.000173	0.000754	CcSEcCtD
Fentanyl—Vomiting—Lovastatin—atherosclerosis	0.000172	0.000749	CcSEcCtD
Fentanyl—Hypersensitivity—Niacin—atherosclerosis	0.000171	0.000745	CcSEcCtD
Fentanyl—Rash—Lovastatin—atherosclerosis	0.00017	0.000743	CcSEcCtD
Fentanyl—Dermatitis—Lovastatin—atherosclerosis	0.00017	0.000742	CcSEcCtD
Fentanyl—Headache—Lovastatin—atherosclerosis	0.000169	0.000738	CcSEcCtD
Fentanyl—Vomiting—Ezetimibe—atherosclerosis	0.000168	0.000734	CcSEcCtD
Fentanyl—Hypersensitivity—Pravastatin—atherosclerosis	0.000168	0.000734	CcSEcCtD
Fentanyl—Dizziness—Simvastatin—atherosclerosis	0.000167	0.000728	CcSEcCtD
Fentanyl—Rash—Ezetimibe—atherosclerosis	0.000167	0.000728	CcSEcCtD
Fentanyl—Dermatitis—Ezetimibe—atherosclerosis	0.000167	0.000728	CcSEcCtD
Fentanyl—Asthenia—Niacin—atherosclerosis	0.000166	0.000726	CcSEcCtD
Fentanyl—Headache—Ezetimibe—atherosclerosis	0.000166	0.000724	CcSEcCtD
Fentanyl—Pruritus—Niacin—atherosclerosis	0.000164	0.000716	CcSEcCtD
Fentanyl—Asthenia—Pravastatin—atherosclerosis	0.000164	0.000715	CcSEcCtD
Fentanyl—Pruritus—Pravastatin—atherosclerosis	0.000161	0.000705	CcSEcCtD
Fentanyl—Vomiting—Simvastatin—atherosclerosis	0.00016	0.0007	CcSEcCtD
Fentanyl—Nausea—Lovastatin—atherosclerosis	0.00016	0.0007	CcSEcCtD
Fentanyl—Rash—Simvastatin—atherosclerosis	0.000159	0.000695	CcSEcCtD
Fentanyl—Dermatitis—Simvastatin—atherosclerosis	0.000159	0.000694	CcSEcCtD
Fentanyl—Diarrhoea—Niacin—atherosclerosis	0.000159	0.000692	CcSEcCtD
Fentanyl—Headache—Simvastatin—atherosclerosis	0.000158	0.00069	CcSEcCtD
Fentanyl—Nausea—Ezetimibe—atherosclerosis	0.000157	0.000686	CcSEcCtD
Fentanyl—Diarrhoea—Pravastatin—atherosclerosis	0.000156	0.000681	CcSEcCtD
Fentanyl—Dizziness—Niacin—atherosclerosis	0.000153	0.000669	CcSEcCtD
Fentanyl—Dizziness—Pravastatin—atherosclerosis	0.000151	0.000659	CcSEcCtD
Fentanyl—Nausea—Simvastatin—atherosclerosis	0.00015	0.000654	CcSEcCtD
Fentanyl—Vomiting—Niacin—atherosclerosis	0.000147	0.000643	CcSEcCtD
Fentanyl—Rash—Niacin—atherosclerosis	0.000146	0.000638	CcSEcCtD
Fentanyl—Dermatitis—Niacin—atherosclerosis	0.000146	0.000637	CcSEcCtD
Fentanyl—Headache—Niacin—atherosclerosis	0.000145	0.000634	CcSEcCtD
Fentanyl—Vomiting—Pravastatin—atherosclerosis	0.000145	0.000633	CcSEcCtD
Fentanyl—Rash—Pravastatin—atherosclerosis	0.000144	0.000628	CcSEcCtD
Fentanyl—Dermatitis—Pravastatin—atherosclerosis	0.000144	0.000627	CcSEcCtD
Fentanyl—Headache—Pravastatin—atherosclerosis	0.000143	0.000624	CcSEcCtD
Fentanyl—Nausea—Niacin—atherosclerosis	0.000138	0.000601	CcSEcCtD
Fentanyl—Nausea—Pravastatin—atherosclerosis	0.000136	0.000592	CcSEcCtD
Fentanyl—Phenylbutazone—PTGS2—atherosclerosis	0.000114	0.0159	CrCbGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—HMOX1—atherosclerosis	1.96e-05	0.000289	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	1.93e-05	0.000285	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MMP3—atherosclerosis	1.92e-05	0.000283	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PIK3CG—atherosclerosis	1.92e-05	0.000283	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP27A1—atherosclerosis	1.92e-05	0.000283	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—SPP1—atherosclerosis	1.91e-05	0.000282	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IGF2—atherosclerosis	1.91e-05	0.000282	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—CXCL8—atherosclerosis	1.9e-05	0.000281	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—APOB—atherosclerosis	1.88e-05	0.000277	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	1.87e-05	0.000277	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—APOB—atherosclerosis	1.85e-05	0.000274	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—CXCL8—atherosclerosis	1.84e-05	0.000271	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—NAMPT—atherosclerosis	1.83e-05	0.000271	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—KNG1—atherosclerosis	1.83e-05	0.00027	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—EDN1—atherosclerosis	1.83e-05	0.000269	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—LIPC—atherosclerosis	1.82e-05	0.000269	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—AGTR1—atherosclerosis	1.82e-05	0.000269	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PLA2G2A—atherosclerosis	1.82e-05	0.000268	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ALOX15—atherosclerosis	1.82e-05	0.000268	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ALOX5AP—atherosclerosis	1.82e-05	0.000268	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—APOA2—atherosclerosis	1.82e-05	0.000268	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—APOC3—atherosclerosis	1.81e-05	0.000267	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CCL5—atherosclerosis	1.81e-05	0.000267	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—LDLR—atherosclerosis	1.8e-05	0.000266	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ABCG5—atherosclerosis	1.79e-05	0.000265	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CCL2—atherosclerosis	1.78e-05	0.000263	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ABCG8—atherosclerosis	1.78e-05	0.000263	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—LTA4H—atherosclerosis	1.78e-05	0.000263	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PLG—atherosclerosis	1.77e-05	0.000262	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—LPL—atherosclerosis	1.77e-05	0.000261	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PDGFB—atherosclerosis	1.77e-05	0.000261	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CETP—atherosclerosis	1.76e-05	0.00026	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	1.75e-05	0.000258	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—LPA—atherosclerosis	1.73e-05	0.000256	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—AGT—atherosclerosis	1.73e-05	0.000255	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PRKCG—atherosclerosis	1.72e-05	0.000254	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—APOE—atherosclerosis	1.69e-05	0.00025	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—LEP—atherosclerosis	1.69e-05	0.00025	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—SCARB1—atherosclerosis	1.68e-05	0.000249	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—HMOX1—atherosclerosis	1.68e-05	0.000248	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SOCS3—atherosclerosis	1.68e-05	0.000248	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—BGN—atherosclerosis	1.68e-05	0.000248	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SPP1—atherosclerosis	1.68e-05	0.000248	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CAV1—atherosclerosis	1.68e-05	0.000248	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—APOA1—atherosclerosis	1.67e-05	0.000247	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—CXCL8—atherosclerosis	1.67e-05	0.000246	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—APOA5—atherosclerosis	1.66e-05	0.000245	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MMP3—atherosclerosis	1.62e-05	0.000239	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ESR1—atherosclerosis	1.62e-05	0.000239	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IGF2—atherosclerosis	1.61e-05	0.000238	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—APOB—atherosclerosis	1.61e-05	0.000238	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PLA2G1B—atherosclerosis	1.6e-05	0.000236	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—F2—atherosclerosis	1.6e-05	0.000236	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—HMGCR—atherosclerosis	1.59e-05	0.000235	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.58e-05	0.000234	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GSTM1—atherosclerosis	1.57e-05	0.000231	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—APOB—atherosclerosis	1.57e-05	0.000231	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—CXCL8—atherosclerosis	1.55e-05	0.000229	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PDGFB—atherosclerosis	1.55e-05	0.000229	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ALOX5—atherosclerosis	1.54e-05	0.000228	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—EDN1—atherosclerosis	1.54e-05	0.000228	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—LPL—atherosclerosis	1.54e-05	0.000227	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CCL5—atherosclerosis	1.53e-05	0.000226	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3CG—atherosclerosis	1.53e-05	0.000226	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—AGT—atherosclerosis	1.51e-05	0.000224	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GPX1—atherosclerosis	1.5e-05	0.000222	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—LPL—atherosclerosis	1.5e-05	0.000221	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.49e-05	0.000219	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—APOE—atherosclerosis	1.48e-05	0.000219	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—LEP—atherosclerosis	1.48e-05	0.000219	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CAV1—atherosclerosis	1.47e-05	0.000217	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—APOA1—atherosclerosis	1.47e-05	0.000217	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—MAPK3—atherosclerosis	1.46e-05	0.000216	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CD36—atherosclerosis	1.46e-05	0.000216	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PRKCG—atherosclerosis	1.46e-05	0.000215	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—INS—atherosclerosis	1.45e-05	0.000213	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CCL2—atherosclerosis	1.42e-05	0.00021	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ABCA1—atherosclerosis	1.42e-05	0.000209	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SPP1—atherosclerosis	1.42e-05	0.000209	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ESR1—atherosclerosis	1.42e-05	0.000209	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—CXCL8—atherosclerosis	1.41e-05	0.000208	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.41e-05	0.000208	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—F2—atherosclerosis	1.4e-05	0.000207	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IGF1—atherosclerosis	1.4e-05	0.000206	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—MTHFR—atherosclerosis	1.39e-05	0.000205	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—NAMPT—atherosclerosis	1.38e-05	0.000204	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—LIPC—atherosclerosis	1.38e-05	0.000203	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—APOC3—atherosclerosis	1.37e-05	0.000202	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PPARA—atherosclerosis	1.36e-05	0.000201	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—LDLR—atherosclerosis	1.36e-05	0.000201	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CG—atherosclerosis	1.34e-05	0.000198	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—SERPINE1—atherosclerosis	1.33e-05	0.000196	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CETP—atherosclerosis	1.33e-05	0.000196	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—FABP4—atherosclerosis	1.32e-05	0.000195	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—LCAT—atherosclerosis	1.32e-05	0.000195	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—AGT—atherosclerosis	1.32e-05	0.000194	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PDGFB—atherosclerosis	1.31e-05	0.000194	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	1.3e-05	0.000192	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APOA4—atherosclerosis	1.3e-05	0.000192	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—APOE—atherosclerosis	1.29e-05	0.00019	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—MAPK3—atherosclerosis	1.28e-05	0.000189	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—AGT—atherosclerosis	1.28e-05	0.000189	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CAV1—atherosclerosis	1.28e-05	0.000189	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.28e-05	0.000188	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—APOA1—atherosclerosis	1.28e-05	0.000188	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—SCARB1—atherosclerosis	1.27e-05	0.000188	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NOS3—atherosclerosis	1.27e-05	0.000187	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—INS—atherosclerosis	1.27e-05	0.000187	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—LEP—atherosclerosis	1.25e-05	0.000185	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—APOE—atherosclerosis	1.25e-05	0.000185	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CCL2—atherosclerosis	1.25e-05	0.000184	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CAV1—atherosclerosis	1.24e-05	0.000183	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—APOA1—atherosclerosis	1.24e-05	0.000183	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IGF1—atherosclerosis	1.23e-05	0.000181	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—HMOX1—atherosclerosis	1.22e-05	0.00018	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—HMGCR—atherosclerosis	1.2e-05	0.000177	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ESR1—atherosclerosis	1.2e-05	0.000177	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—F2—atherosclerosis	1.18e-05	0.000175	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.18e-05	0.000174	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—ALB—atherosclerosis	1.18e-05	0.000174	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—APOB—atherosclerosis	1.17e-05	0.000172	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SERPINE1—atherosclerosis	1.16e-05	0.000172	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CG—atherosclerosis	1.16e-05	0.000172	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GSTM1—atherosclerosis	1.13e-05	0.000167	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CG—atherosclerosis	1.13e-05	0.000167	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CXCL8—atherosclerosis	1.12e-05	0.000166	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PPARG—atherosclerosis	1.12e-05	0.000166	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APOA2—atherosclerosis	1.12e-05	0.000165	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.12e-05	0.000165	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.12e-05	0.000165	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.12e-05	0.000165	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—LPL—atherosclerosis	1.11e-05	0.000164	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NOS3—atherosclerosis	1.11e-05	0.000164	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.1e-05	0.000163	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—INS—atherosclerosis	1.1e-05	0.000163	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—AKT1—atherosclerosis	1.09e-05	0.00016	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GPX1—atherosclerosis	1.09e-05	0.00016	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—MAPK3—atherosclerosis	1.08e-05	0.00016	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—INS—atherosclerosis	1.07e-05	0.000158	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ABCA1—atherosclerosis	1.07e-05	0.000158	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IL6—atherosclerosis	1.07e-05	0.000158	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—LPA—atherosclerosis	1.07e-05	0.000158	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CD36—atherosclerosis	1.06e-05	0.000156	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CCL2—atherosclerosis	1.05e-05	0.000156	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IGF1—atherosclerosis	1.04e-05	0.000153	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—BGN—atherosclerosis	1.03e-05	0.000153	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APOA5—atherosclerosis	1.02e-05	0.000151	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MMP9—atherosclerosis	1.02e-05	0.00015	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ALB—atherosclerosis	1.01e-05	0.000149	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—NFKB1—atherosclerosis	1.01e-05	0.000149	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—MTHFR—atherosclerosis	1e-05	0.000148	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MAPK8—atherosclerosis	9.89e-06	0.000146	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—AKT1—atherosclerosis	9.87e-06	0.000146	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CXCL8—atherosclerosis	9.86e-06	0.000146	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	9.85e-06	0.000145	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SERPINE1—atherosclerosis	9.84e-06	0.000145	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PPARA—atherosclerosis	9.83e-06	0.000145	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—NOS3—atherosclerosis	9.67e-06	0.000143	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—AKT1—atherosclerosis	9.53e-06	0.000141	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—AGT—atherosclerosis	9.52e-06	0.000141	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ALOX5—atherosclerosis	9.51e-06	0.00014	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NOS3—atherosclerosis	9.4e-06	0.000139	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL6—atherosclerosis	9.38e-06	0.000138	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—APOE—atherosclerosis	9.33e-06	0.000138	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CAV1—atherosclerosis	9.24e-06	0.000136	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—APOA1—atherosclerosis	9.22e-06	0.000136	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—HMOX1—atherosclerosis	9.18e-06	0.000136	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—VEGFA—atherosclerosis	9.14e-06	0.000135	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—STAT3—atherosclerosis	9.05e-06	0.000134	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MMP9—atherosclerosis	8.92e-06	0.000132	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PTGS2—atherosclerosis	8.84e-06	0.000131	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—NFKB1—atherosclerosis	8.83e-06	0.00013	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—APOB—atherosclerosis	8.79e-06	0.00013	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MAPK8—atherosclerosis	8.68e-06	0.000128	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—AKT1—atherosclerosis	8.65e-06	0.000128	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MAPK3—atherosclerosis	8.64e-06	0.000128	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GSTM1—atherosclerosis	8.55e-06	0.000126	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NAMPT—atherosclerosis	8.53e-06	0.000126	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—LIPC—atherosclerosis	8.48e-06	0.000125	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APOC3—atherosclerosis	8.42e-06	0.000124	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CG—atherosclerosis	8.42e-06	0.000124	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—LPL—atherosclerosis	8.4e-06	0.000124	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TGFB1—atherosclerosis	8.39e-06	0.000124	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—LDLR—atherosclerosis	8.37e-06	0.000124	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CXCL8—atherosclerosis	8.34e-06	0.000123	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GPX1—atherosclerosis	8.19e-06	0.000121	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CETP—atherosclerosis	8.18e-06	0.000121	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PPARG—atherosclerosis	8.12e-06	0.00012	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—AKT1—atherosclerosis	8.05e-06	0.000119	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—VEGFA—atherosclerosis	8.01e-06	0.000118	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CD36—atherosclerosis	7.98e-06	0.000118	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—INS—atherosclerosis	7.97e-06	0.000118	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—STAT3—atherosclerosis	7.93e-06	0.000117	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL6—atherosclerosis	7.93e-06	0.000117	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—SCARB1—atherosclerosis	7.83e-06	0.000116	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MAPK3—atherosclerosis	7.58e-06	0.000112	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—MTHFR—atherosclerosis	7.56e-06	0.000112	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MMP9—atherosclerosis	7.54e-06	0.000111	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—NFKB1—atherosclerosis	7.46e-06	0.00011	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PPARA—atherosclerosis	7.42e-06	0.000109	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HMGCR—atherosclerosis	7.4e-06	0.000109	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TGFB1—atherosclerosis	7.35e-06	0.000109	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MAPK8—atherosclerosis	7.33e-06	0.000108	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—AKT1—atherosclerosis	7.31e-06	0.000108	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ALB—atherosclerosis	7.3e-06	0.000108	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—AGT—atherosclerosis	7.18e-06	0.000106	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—APOE—atherosclerosis	7.04e-06	0.000104	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—NOS3—atherosclerosis	6.99e-06	0.000103	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CAV1—atherosclerosis	6.97e-06	0.000103	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—APOA1—atherosclerosis	6.96e-06	0.000103	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—VEGFA—atherosclerosis	6.77e-06	9.99e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—STAT3—atherosclerosis	6.7e-06	9.9e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ABCA1—atherosclerosis	6.59e-06	9.73e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MAPK3—atherosclerosis	6.4e-06	9.45e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PTGS2—atherosclerosis	6.39e-06	9.43e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CG—atherosclerosis	6.35e-06	9.38e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL6—atherosclerosis	6.32e-06	9.33e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TGFB1—atherosclerosis	6.21e-06	9.17e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PPARG—atherosclerosis	6.13e-06	9.05e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—INS—atherosclerosis	6.01e-06	8.88e-05	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—AKT1—atherosclerosis	5.83e-06	8.61e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HMOX1—atherosclerosis	5.66e-06	8.35e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL6—atherosclerosis	5.54e-06	8.18e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ALB—atherosclerosis	5.51e-06	8.14e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APOB—atherosclerosis	5.42e-06	8e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—NOS3—atherosclerosis	5.27e-06	7.78e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTM1—atherosclerosis	5.27e-06	7.78e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—LPL—atherosclerosis	5.17e-06	7.64e-05	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—AKT1—atherosclerosis	5.11e-06	7.55e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GPX1—atherosclerosis	5.05e-06	7.45e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CD36—atherosclerosis	4.91e-06	7.26e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PTGS2—atherosclerosis	4.82e-06	7.12e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL6—atherosclerosis	4.68e-06	6.91e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—MTHFR—atherosclerosis	4.66e-06	6.88e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PPARA—atherosclerosis	4.57e-06	6.75e-05	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—AKT1—atherosclerosis	4.44e-06	6.56e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—AGT—atherosclerosis	4.43e-06	6.53e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APOE—atherosclerosis	4.34e-06	6.4e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—AKT1—atherosclerosis	4.32e-06	6.38e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CAV1—atherosclerosis	4.3e-06	6.34e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—APOA1—atherosclerosis	4.29e-06	6.33e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CG—atherosclerosis	3.91e-06	5.78e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PPARG—atherosclerosis	3.78e-06	5.58e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—INS—atherosclerosis	3.7e-06	5.47e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ALB—atherosclerosis	3.4e-06	5.01e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NOS3—atherosclerosis	3.25e-06	4.8e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—AKT1—atherosclerosis	3.21e-06	4.74e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PTGS2—atherosclerosis	2.97e-06	4.39e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—AKT1—atherosclerosis	2.42e-06	3.58e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—AKT1—atherosclerosis	1.49e-06	2.2e-05	CbGpPWpGaD
